Category: Disclosures

[Disclosure] ISU PETASYS(007660) – Results of Rights Offering / Issuance of Equity-Related Bonds (Voluntary Disclosure) / 2025-04-17

April 17, 2025August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has completed the payment process for its rights offering, successfully raising approximately KRW 282.5 billion by issuing 10,162,800 common shares. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring New Share Listing Schedule and Capital Inflow Impact This…

Semiconductors, Disclosures

[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2025-04-17

April 17, 2025August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics has announced in advance that it plans to disclose its provisional Q1 2025 financial results on April 29, 2025. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Earnings Release Disclosure and Final Confirmed Figures Through this…

Semiconductors, Disclosures

[Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2025-04-17

April 17, 2025August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics is hosting an Investor Relations (IR) event for domestic institutional investors to present its Q1 2025 financial results and business outlook. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of IR Presentation Materials and Confirmed Financial Results…

Semiconductors, Disclosures

[Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2025-04-17

April 17, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor will hold a conference call on April 24, 2025, at 14:10 KST to announce its Q1 2025 business performance to institutional investors and analysts. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of IR Schedule and…

Disclosures, Automotive

[Disclosure] Hanwha Ocean (042660) – (Correction) Loan Decision / 2025-04-16

April 16, 2025August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing is a corrected disclosure by Hanwha Ocean adjusting the transaction date and loan period (from April 22, 2025 to April 22, 2040) regarding its shareholder loan decision for affiliate Tidal Action LLC. 📊 Key Filing Details & Key Figures Summary 1. Correction Details &…

Disclosures, Shipbuilding

[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Holding / 2025-04-16

April 16, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems will hold an Investor Relations (IR) event via conference call and webcast on April 29, 2025, at 10:00 KST for shareholders, analysts, institutional investors, and media to present its Q1 2025 earnings and conduct a Q&A session. 📊 [Key Disclosure Details & Financial Highlights]…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Advance Notice of Market Measures on Stock Futures and Options / 2025-04-15

April 15, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace re-announced the planned schedule for market measures—including adjustments to reference prices, contract multipliers, and exercise prices for stock futures and options—set to take effect on the ex-rights date (April 23, 2025) following its capital increase decision. 📊 [Key Disclosure Contents & Major Figures Summary]…

Disclosures, Defense

[Disclosure] Celltrion (068270) – Approval of Supplemental sBLA for Interchangeability Designation of Yuflyma (CT-P17, Humira Biosimilar) in the U.S. / 2025-04-14

April 14, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received approval from the U.S. FDA for a supplemental Biologics License Application (sBLA) securing interchangeability status for Yuflyma, its Humira biosimilar. This designation allows Yuflyma to be substituted for the reference product at the pharmacy level without the intervention of a prescribing physician. 📊 Key…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Financial Results Release / 2025-04-14

April 14, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace announced that it is scheduled to release its preliminary consolidated financial results for Q1 2025 (January 1, 2025 – March 31, 2025) on April 30, 2025. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Details of Earnings Release Pre-announcement 2. Other Material Matters…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding Notice / 2025-04-14

April 14, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace announced that it will hold a Q1 2025 Investor Relations (IR) conference call and webcasting for investors and analysts on April 30, 2025, to present its Q1 2025 financial results and hold a Q&A session. 📊 [Key Disclosure Contents & Major Figures Summary] 1….

Disclosures, Defense